Lipoprotein(a)

An underrecognized genetic risk factor for malignant coronary artery disease in young Indians

Enas A. Enas, Basil Varkey, Thiruvinvamalai S. Dharmarajan, Guillaume Pare, Vinay K. Bahl

Research output: Contribution to journalReview article

Abstract

Malignant coronary artery disease (CAD)refers to a severe and extensive atherosclerotic process involving multiple coronary arteries in young individuals (aged <45 years in men and <50 years in women)with a low or no burden of established risk factors. Indians, in general, develop acute myocardial infarction (AMI)about 10 years earlier; AMI rates are threefold to fivefold higher in young Indians than in other populations. Although established CAD risk factors have a predictive value, they do not fully account for the excessive burden of CAD in young Indians. Lipoprotein(a)(Lp(a))is increasingly recognized as the strongest known genetic risk factor for premature CAD, with high levels observed in Indians with malignant CAD. High Lp(a)levels confer a twofold to threefold risk of CAD—a risk similar to that of established risk factors, including diabetes. South Asians have the second highest Lp(a)levels and the highest risk of AMI from the elevated levels, more than double the risk observed in people of European descent. Approximately 25% of Indians and other South Asians have elevated Lp(a)levels (≥50 mg/dl), rendering Lp(a)a risk factor of great importance, similar to or surpassing diabetes. Lp(a)measurement is ready for clinical use and should be an essential part of all CAD research in Indians.

Original languageEnglish (US)
JournalIndian Heart Journal
DOIs
StatePublished - Jan 1 2019

Fingerprint

Lipoprotein(a)
Coronary Artery Disease
Myocardial Infarction
Coronary Vessels
Research
Population

Keywords

  • Acute coronary syndrome
  • Acute myocardial infarction
  • ASCVD risk enhancing factor
  • Cardiovascular disease
  • Coronary artery disease
  • Indians
  • Lipoprotein(a)
  • Lp(a)-years
  • Malignant coronary artery disease
  • Mendelian randomization
  • Standardized mortality ratio

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lipoprotein(a) : An underrecognized genetic risk factor for malignant coronary artery disease in young Indians. / Enas, Enas A.; Varkey, Basil; Dharmarajan, Thiruvinvamalai S.; Pare, Guillaume; Bahl, Vinay K.

In: Indian Heart Journal, 01.01.2019.

Research output: Contribution to journalReview article

@article{4b05ee6017eb4420881d138671987385,
title = "Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians",
abstract = "Malignant coronary artery disease (CAD)refers to a severe and extensive atherosclerotic process involving multiple coronary arteries in young individuals (aged <45 years in men and <50 years in women)with a low or no burden of established risk factors. Indians, in general, develop acute myocardial infarction (AMI)about 10 years earlier; AMI rates are threefold to fivefold higher in young Indians than in other populations. Although established CAD risk factors have a predictive value, they do not fully account for the excessive burden of CAD in young Indians. Lipoprotein(a)(Lp(a))is increasingly recognized as the strongest known genetic risk factor for premature CAD, with high levels observed in Indians with malignant CAD. High Lp(a)levels confer a twofold to threefold risk of CAD—a risk similar to that of established risk factors, including diabetes. South Asians have the second highest Lp(a)levels and the highest risk of AMI from the elevated levels, more than double the risk observed in people of European descent. Approximately 25{\%} of Indians and other South Asians have elevated Lp(a)levels (≥50 mg/dl), rendering Lp(a)a risk factor of great importance, similar to or surpassing diabetes. Lp(a)measurement is ready for clinical use and should be an essential part of all CAD research in Indians.",
keywords = "Acute coronary syndrome, Acute myocardial infarction, ASCVD risk enhancing factor, Cardiovascular disease, Coronary artery disease, Indians, Lipoprotein(a), Lp(a)-years, Malignant coronary artery disease, Mendelian randomization, Standardized mortality ratio",
author = "Enas, {Enas A.} and Basil Varkey and Dharmarajan, {Thiruvinvamalai S.} and Guillaume Pare and Bahl, {Vinay K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ihj.2019.04.007",
language = "English (US)",
journal = "Indian Heart Journal",
issn = "0019-4832",
publisher = "Cardiology Society of India",

}

TY - JOUR

T1 - Lipoprotein(a)

T2 - An underrecognized genetic risk factor for malignant coronary artery disease in young Indians

AU - Enas, Enas A.

AU - Varkey, Basil

AU - Dharmarajan, Thiruvinvamalai S.

AU - Pare, Guillaume

AU - Bahl, Vinay K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Malignant coronary artery disease (CAD)refers to a severe and extensive atherosclerotic process involving multiple coronary arteries in young individuals (aged <45 years in men and <50 years in women)with a low or no burden of established risk factors. Indians, in general, develop acute myocardial infarction (AMI)about 10 years earlier; AMI rates are threefold to fivefold higher in young Indians than in other populations. Although established CAD risk factors have a predictive value, they do not fully account for the excessive burden of CAD in young Indians. Lipoprotein(a)(Lp(a))is increasingly recognized as the strongest known genetic risk factor for premature CAD, with high levels observed in Indians with malignant CAD. High Lp(a)levels confer a twofold to threefold risk of CAD—a risk similar to that of established risk factors, including diabetes. South Asians have the second highest Lp(a)levels and the highest risk of AMI from the elevated levels, more than double the risk observed in people of European descent. Approximately 25% of Indians and other South Asians have elevated Lp(a)levels (≥50 mg/dl), rendering Lp(a)a risk factor of great importance, similar to or surpassing diabetes. Lp(a)measurement is ready for clinical use and should be an essential part of all CAD research in Indians.

AB - Malignant coronary artery disease (CAD)refers to a severe and extensive atherosclerotic process involving multiple coronary arteries in young individuals (aged <45 years in men and <50 years in women)with a low or no burden of established risk factors. Indians, in general, develop acute myocardial infarction (AMI)about 10 years earlier; AMI rates are threefold to fivefold higher in young Indians than in other populations. Although established CAD risk factors have a predictive value, they do not fully account for the excessive burden of CAD in young Indians. Lipoprotein(a)(Lp(a))is increasingly recognized as the strongest known genetic risk factor for premature CAD, with high levels observed in Indians with malignant CAD. High Lp(a)levels confer a twofold to threefold risk of CAD—a risk similar to that of established risk factors, including diabetes. South Asians have the second highest Lp(a)levels and the highest risk of AMI from the elevated levels, more than double the risk observed in people of European descent. Approximately 25% of Indians and other South Asians have elevated Lp(a)levels (≥50 mg/dl), rendering Lp(a)a risk factor of great importance, similar to or surpassing diabetes. Lp(a)measurement is ready for clinical use and should be an essential part of all CAD research in Indians.

KW - Acute coronary syndrome

KW - Acute myocardial infarction

KW - ASCVD risk enhancing factor

KW - Cardiovascular disease

KW - Coronary artery disease

KW - Indians

KW - Lipoprotein(a)

KW - Lp(a)-years

KW - Malignant coronary artery disease

KW - Mendelian randomization

KW - Standardized mortality ratio

UR - http://www.scopus.com/inward/record.url?scp=85066156465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066156465&partnerID=8YFLogxK

U2 - 10.1016/j.ihj.2019.04.007

DO - 10.1016/j.ihj.2019.04.007

M3 - Review article

JO - Indian Heart Journal

JF - Indian Heart Journal

SN - 0019-4832

ER -